Paolo Gresele
Overview
Explore the profile of Paolo Gresele including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
225
Citations
3884
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guglielmini G, Berardi E, Messina F, Marcotullio M, Gresele P
Pharmacol Rep
. 2025 Feb;
PMID: 39998803
Background: Resveratrol is a polyphenol of red wine that is thought to contribute to the "French paradox" by protecting against atherosclerotic cardiovascular events. It has anti-inflammatory and antioxidant properties and...
2.
Boilard E, Burger D, Buzas E, Gresele P, Machlus K, Mackman N, et al.
Circ Res
. 2025 Feb;
136(4):442-452.
PMID: 39946441
Platelets are abundant in blood, where they maintain the integrity of the vasculature. Megakaryocytes, the cells responsible for platelet genesis, produce membrane protrusions from which as many as 5000 anucleate...
3.
Paciullo F, Gresele P
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941509
The risk of cardiovascular events increases considerably after an acute coronary syndrome (ACS), particularly in the first few months. Dual antiplatelet therapy represents the mainstay of secondary prevention during this...
4.
de Sio V, Gragnano F, Capolongo A, Guarnaccia N, Maddaluna P, Acerbo V, et al.
Int J Cardiol
. 2025 Jan;
423:133028.
PMID: 39890028
Aims: Semaglutide has been shown to reduce cardiovascular events in non-diabetic patients with preexisting cardiovascular disease and overweight/obesity in the SELECT trial. Data on the applicability of these results to...
5.
Ernst M, Versluis J, Valk P, Bierings M, Tamminga R, Hooimeijer L, et al.
Hemasphere
. 2025 Jan;
9(1):e70057.
PMID: 39822584
Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM, FPD/AML, -FPD), caused by monoallelic deleterious germline variants, is characterized by bleeding diathesis and predisposition for hematologic malignancies, particularly myelodysplastic syndrome (MDS)...
6.
Momi S, Gresele P
Semin Thromb Hemost
. 2024 Nov;
PMID: 39561814
Atherosclerosis is a chronic, multifactorial inflammatory disorder of large and medium-size arteries, which is the leading cause of cardiovascular mortality and morbidity worldwide. Although platelets in cardiovascular disease have mainly...
7.
Petito E, Bury L, Antunes Heck L, Sadler B, De Candia E, Podda G, et al.
Br J Haematol
. 2024 Oct;
206(1):290-295.
PMID: 39462764
No risk factors have been identified for vaccine-induced immune thrombotic thrombocytopenia (VITT) so far. The aim of this study was to identify human leucocyte antigen (HLA) alleles potentially associated with...
8.
Christensen R, Yi M, Kang B, Ibrahim S, Anvery N, Dirr M, et al.
J Clin Epidemiol
. 2024 Oct;
175:111514.
PMID: 39353833
No abstract available.
9.
Benemei S, Gatto F, Marcucci R, Gresele P
Thromb Haemost
. 2024 Sep;
PMID: 39260400
Gene therapy is a promising therapeutic approach for treating life-threatening disorders. Despite the clinical improvements observed with gene therapy, immune responses either innate or adaptive against the vector used for...
10.
Abad-Motos A, Garcia-Erce J, Gresele P, Paramo J
Curr Opin Crit Care
. 2024 Sep;
30(6):655-663.
PMID: 39248078
Purpose Of Review: Tranexamic acid (TXA), an antifibrinolytic agent, reduces surgical bleeding in a variety of procedures, such as cardiac, orthopedic, abdominal, and urologic surgery, cesarean section, and neurosurgery. However,...